Publikationen am BMWZ
2022
Fritsch, S., Gasser, V., Peukert, C., Pinkert, L., Kuhn, L., Perraud, Q., Normant, V., Brönstrup, M., & Schalk, I. J. (2022). Uptake Mechanisms and Regulatory Responses to MECAM- and DOTAM-Based Artificial Siderophores and Their Antibiotic Conjugates in Pseudomonas aeruginosa. ACS infectious diseases, 8(6), 1134-1146.
Hotop, S. K., Reimering, S., Shekhar, A., Asgari, E., Beutling, U., Dahlke, C., Fathi, A., Khan, F., Lütgehetmann, M., Ballmann, R., Gerstner, A., Tegge, W., Cicin-Sain, L., Bilitewski, U., McHardy, A. C., & Brönstrup, M. (2022). Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2. Emerging Microbes and Infections, 11(1), 1037-1048.
Napolitano, V., Dabrowska, A., Schorpp, K., Mourão, A., Barreto-Duran, E., Benedyk, M., Botwina, P., Brandner, S., Bostock, M., Chykunova, Y., Czarna, A., Dubin, G., Fröhlich, T., Hölscher, M., Jedrysik, M., Matsuda, A., Owczarek, K., Pachota, M., Plettenburg, O., ... Pyrc, K. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chemical Biology, 29(5), 774-784.
Yin, H., Karayel, O., Chao, Y. Y., Seeholzer, T., Hamp, I., Plettenburg, O., Gehring, T., Zielinski, C., Mann, M., & Krappmann, D. (2022). A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. Cellular and Molecular Life Sciences, 79(2), [112].
2021
Arisetti, N., Fuchs, H. L. S., Coetzee, J., Orozco, M., Ruppelt, D., Bauer, A., Heimann, D., Kuhnert, E., Bhamidimarri, S. P., Bafna, J. A., Hinkelmann, B., Eckel, K., Sieber, S. A., Müller, P. P., Herrmann, J., Müller, R., Winterhalter, M., Steinem, C., & Brönstrup, M. (2021). Total synthesis and mechanism of action of the antibiotic armeniaspirol A. Chemical science, 12(48), 16023-16034.
Becker, K., Pfütze, S., Kuhnert, E., Cox, R. J., Stadler, M., & Surup, F. (2021). Hybridorubrins A-D: Azaphilone Heterodimers from Stromata of Hypoxylon fragiforme and Insights into the Biosynthetic Machinery for Azaphilone Diversification. Chemistry - A European Journal, 27(4), 1438-1450.
Eggert, A., Etling, C., Millbrodt, L., Schulz, G., & Kalesse, M. (2021). Oxazaborolidinone-Mediated Asymmetric Bisvinylogous Mukaiyama Aldol Reaction. Organic letters, 23(22), 8722-8726.
Gerckens, M., Schorpp, K., Pelizza, F., Wögrath, M., Reichau, K., Ma, H., Dworsky, A. M., Sengupta, A., Stoleriu, M. G., Heinzelmann, K., Merl-Pham, J., Irmler, M., Alsafadi, H. N., Trenkenschuh, E., Sarnova, L., Jirouskova, M., Frieß, W., Hauck, S. M., Beckers, J., ... Burgstaller, G. (2021). Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics. Science advances, 7(52), [eabb3673].
Hamp, I., O’Neill, T. J., Plettenburg, O., & Krappmann, D. (2021). A patent review of MALT1 inhibitors (2013-present). Expert Opinion on Therapeutic Patents, 31(12), 1079-1096.
Kahlert, L., Bernardi, D., Hauser, M., Ióca, L. P., Berlinck, R. G. S., Skellam, E. J., & Cox, R. J. (2021). Early Oxidative Transformations During the Biosynthesis of Terrein and Related Natural Products. Chemistry – A European Journal, 27(46), 11895-11903.
